Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.
Hum Mol Genet. 2012 Oct 1;21(19):4286-300. doi: 10.1093/hmg/dds262. Epub 2012 Jun 29.
Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder with prominent brain manifestations due to mutations in either TSC1 or TSC2. Here, we describe novel mouse brain models of TSC generated using conditional hypomorphic and null alleles of Tsc2 combined with the neuron-specific synapsin I cre (SynIcre) allele. This allelic series of homozygous conditional hypomorphic alleles (Tsc2(c-del3/c-del3)SynICre(+)) and heterozygote null/conditional hypomorphic alleles (Tsc2(k/c-del3)SynICre(+)) achieves a graded reduction in expression of Tsc2 in neurons in vivo. The mice demonstrate a progressive neurologic phenotype including hunchback, hind limb clasp, reduced survival and brain and cortical neuron enlargement that correlates with a graded reduction in expression of Tsc2 in the two sets of mice. Both models also showed behavioral abnormalities in anxiety, social interaction and learning assays, which correlated with Tsc2 protein levels as well. The observations demonstrate that there are graded biochemical, cellular and clinical/behavioral effects that are proportional to the extent of reduction in Tsc2 expression in neurons. Further, they suggest that some patients with milder manifestations of TSC may be due to persistent low-level expression of functional protein from their mutant allele. In addition, they point to the potential clinical benefit of strategies to raise TSC2 protein expression from the wild-type allele by even modest amounts.
结节性硬化症(TSC)是一种神经发育障碍,由于 TSC1 或 TSC2 的突变,其大脑表现突出。在这里,我们描述了使用 Tsc2 的条件性功能缺失和缺失等位基因与神经元特异性突触素 I cre(SynIcre)等位基因结合产生的新型 TSC 小鼠脑模型。该等位基因系列的纯合条件性功能缺失等位基因(Tsc2(c-del3/c-del3)SynICre(+))和杂合缺失/条件性功能缺失等位基因(Tsc2(k/c-del3)SynICre(+))在体内实现了 Tsc2 在神经元中的表达逐渐降低。这些小鼠表现出进行性神经表型,包括驼背、后肢扣状、存活率降低以及大脑和皮质神经元增大,与两组小鼠中 Tsc2 的表达逐渐降低相关。这两种模型还表现出焦虑、社交互动和学习测试中的行为异常,这与 Tsc2 蛋白水平也相关。这些观察结果表明,存在与神经元中 Tsc2 表达减少程度成正比的分级生化、细胞和临床/行为效应。此外,它们表明一些 TSC 表现较轻的患者可能是由于其突变等位基因持续低水平表达功能性蛋白所致。此外,它们还表明,通过适度提高野生型等位基因的 TSC2 蛋白表达水平可能具有潜在的临床获益。